RLX-33
RLX-33 is a potent, selective and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist, also blocks relaxin-3-induced ERK1/2 phosphorylation, with IC50 values of 2.36 μM for RXFP3, 7.82 and 13.86 μM for ERK1 and ERK2 phosphorylation, respectively. RLX-33 can block the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats. RLX-33 can be used for the research of metabolic syndrome[1].
Product Specifications
CAS Number
2784577-71-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rlx-33.html
Concentration
10mM
Purity
99.79
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C(C1)CN(CC2=CC=CO2)C1=O)NC3=CC=C(C4=NC(C5=CC=C(Cl)C=C5)=NO4)C=C3
Molecular Formula
C24H19ClN4O4
Molecular Weight
462.89
Precautions
H302, H315, H319
References & Citations
[1]https://pubmed.ncbi.nlm.nih.gov/35594150/
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human sC5b-9 (Soluble Terminal Complement Complex C5b-9) CLIA Kit
Human sC5b-9 (Soluble Terminal Complement Complex C5b-9) CLIA Kit
Human sC5b-9 (Soluble Terminal Complement Complex C5b-9) CLIA Kit
